期刊文献+

BRCA1在鼻咽癌中的表达及与预后关系的研究 被引量:2

Research of the relationship between expression of BRCA1 and prognosis in nasopharyngeal cancinoma
暂未订购
导出
摘要 目的观察乳癌基因1(BRCA1)在鼻咽癌中的表达水平并分析其表达水平与预后的关系。方法采用免疫组化S-P法检测100例患者鼻咽癌组织中BRCA1蛋白的表达水平,阳性细胞计数≥50%定为BRCA1高表达组;<50%及不表达者定为BRCA1低表达组。应用χ2检验对BRCA1表达水平与临床资料进行关联性分析。结果 100例患者中13例失访,BRCA1高表达者37例(42.5%),低表达者50例(57.5%);BRCA1表达与患者的临床分期(P=0.383)、原发灶退缩情况(P=0.434)、肿瘤发生远处转移(P=0.055)无明显关联性,高表达组生存率稍高于低表达组,但差异无统计学意义(P>0.05)。结论鼻咽癌组织中BRCA1蛋白的表达与临床分期和原发灶退缩程度无关,但BRCA1低表达者更易出现远处转移的趋势。 Objective To investigate the protein expression of Breast cancer 1(BRCA1) in nasopharyngeal carcinoma(NPC) and to analyze the relationship of BRCA1 expression with the prognosis.Methods The expression of BRCA1 proteins in the tissue of nasopharyngeal carcinoma in 100 patients with NPC was detected by immunohisto-chemistry.The high BRCA1 expression group included patients whose biopsy specimens showed at least 50%immu-nopositive tumor cells;The low BRCA1 expression group included patients whose biopsy specimens showed less than 50% immunopositive tumor cells , including negative expression .The correlations between protein expression and clin-ical data were assessed using the chi-square test.Results Thirteen patients failed to be followed-up.And in the rest 87 patients, the high BRCA1 expression group and low BRCA 1 expression group included 37 patients(42.5%) and 50 patients(57.5%) respectively.No significant differences were found between the expression of BRCA 1 proteins and TNM stage(P=0.383), tumor regression(P=0.434), or distant metastasis(P=0.055).The survival rate in the high BRCA1 expression group was higher than that in the low BRCA 1 expression group , but there was no statisti-cally significant differences between two groups ( P&gt;0.05 ) .Conclusion There was no significant correlation be-tween the expression level of BRCA 1 and TNM stage and tumor regression in nasopharyngeal carcinoma .However ,the low expression of BRCA 1 were more prone to metastasis tendency .
出处 《中国临床新医学》 2014年第2期95-98,共4页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金 国家自然科学基金资助项目(编号:81260348) 广西卫生厅重点科研课题(编号:桂卫重2010037)
关键词 鼻咽癌 乳癌基因1 预后 BREAST cancer1(BRCA1) Nasopharyngeal cancinoma Prognosis
  • 相关文献

参考文献3

二级参考文献68

  • 1曹建平,E.Fritz,郑斯英,朱巍,罗加林,周献锋,王明明.酵母TEL1基因对辐射诱发A-T细胞染色体畸变的影响[J].中华放射医学与防护杂志,2004,24(3):192-195. 被引量:6
  • 2赵充.鼻咽癌调强适形放疗进展[J].实用肿瘤杂志,2004,19(4):281-284. 被引量:39
  • 3Xia P,Fu KK,Wong GW,et al.Comparision of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma.Int J Radiat Oncol Biol Phys,2000,48:329-337.
  • 4Balogh JM,Sutherland SE.Osteoradionecrosis of the mandible:a review.J Otolaryngol,1989,18:245-250.
  • 5Cooper JS,Fu K,Marks J,et al.Late effects of radiation therapy in the head and neck region.Int J Radiat Oncol Biol Phys,1995,31:1141-1164.
  • 6Langendijk JA,Leemans ChR,Buter J,et al.The Additional Value of Chemotherapy to Radiotherapy in Locally Advanced Nasopharyngeal Carcinoma:a Meta-Analysis of the Published Literature.J Clin Oncol,2004,22:4604-4612.
  • 7Marks JE,Bedwinek JM,Lee F,et al.Dose-response analysis for nasopharyngeal carcinoma:a historical perspective.Cancer,1982,50:1042-1050.
  • 8Vikram B,Mishra UB,Strong EW,et al.Patterns of failure in carcinoma of the nasopharynx:I.Failure at the primary site.Int J Radiat Oncol Biol Phys,1985,11:1455-1459.
  • 9Sultanem K,Shu HK,Xia P,et al.Three dimensional intensity-modulated radiotherapy n the treatment of nasopharyngeal carcinoma:the university of California-San Francisco experiences.Int J Radiat Oncol Biol Phys,2000,48:711-722.
  • 10Lee N,Xia P,Quivey JM,et al.Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma:An update of the UCSF experience.Int J Radiat Oncol Biol Phys,2002,53:12-22.

共引文献163

同被引文献17

  • 1魏琳琳,王蕊,关淑梅.老年宫颈鳞癌患者癌组织中细胞周期检测点激酶1、2和DNA双链断裂修复蛋白51的表达及意义[J].中国老年学杂志,2014,34(12):3266-3268. 被引量:2
  • 2James C R, Quinn J E, Mullan P B, et al. BRCA1, a potentialpredictive biomarker in the treatment of breast cancer[J]. On-cologist, 2007,12(2) : 142-150.
  • 3Soderlund K, Skoog L,Fornander T,et al. The BRCAl/BRCA2/Rad51 complex is a prognostic and predictive factor inearly breast cancer[J]. Radiother Oncol,2007,84(3) : 242-251.
  • 4Jakubowska A, Gronwald J,Menkiszak J,et al. The RAD511350 C polymorphism modifies breast cancer and ovariancancer risk in Polish BRCAl mutation carriers[J]. Cancer Epi-demiol Biomarkers Prev, 2007 ,16(2) : 270-275.
  • 5Bahassi E M,Ovesen J L,Riesenberg A \:et al. The checkpointkinase chk land chk 2 regulate the function al associations be-tween Hbrca2 and Rad51 in response to DNA damage[J]. Onco-gene, 2008 ,27(28) : 3977-3985.
  • 6Miyai K,FurugenY,Matsumoto T,et al. Loss of heterozygosityanalysis in uterine cervical adenocarcinoma [J ]. Gynecol Oncol,2004,94(1):115-120.
  • 7Tassone P,Tagliaferri P, Perricelli A, et al. BRCAl expressionmodulates chemosensitivity of BRCA 1-defective HCC1937 hu-man breast cancer cel Is [J]. Br J Cancer, 2003,88 ( 8) : 1285-1291.
  • 8Wang L, Wei J ,Qian X, et al. ERCC1 and BRCAl mRNA ex-pression levels in metastatic malignant effusions is associatedwith chemosensitivity to cisplatin and/or docetaxel [J]. BMCCancer,2008,8(4) :97.
  • 9Collis S J,Tighe A,Scott S D,et al. Ribozyme minigene-media-ted RAD51 down-regulation increases radiosensitivity ofhumanprostate cancer cells[J]. Nucleic Acids Res, 2001,29(7) : 1534-1538.
  • 10彭亚婷,梅金红.Rad51与肿瘤关系的研究进展[J].临床与实验病理学杂志,2011,27(1):86-89. 被引量:9

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部